Literature DB >> 1673644

Continuous vecuronium infusion for prolonged muscle relaxation in children.

K T Fitzpatrick1, G W Black, P M Crean, R K Mirakhur.   

Abstract

Facilitation of mechanical ventilation of the lungs using an infusion of vecuronium in 11 infants and children and four neonates in an intensive care unit is described. A loading dose of vecuronium of 0.1 mg.kg-1 was followed by an infusion at an initial rate of 0.1 mg.kg-1.hr-1. The infusion rate was adjusted to maintain a neuromuscular block of approximately 90% as assessed by the presence of one response to a train-of-four stimulation. The duration of the infusions varied from 9.5 to 179 hr. The mean dose of vecuronium administered was 0.14 mg.kg-1.hr-1 (+/- 0.05, SD) in the children and 0.11 mg.kg-1.hr-1 (+/- 0.05) in the neonates. Mean recovery times from the time of stopping the infusion until absence of apparent fade in response to tetanic stimulation were 51.7 (+/- 17.6) and 46.8 (+/- 16.5) min for the children and neonates respectively. No adverse cardiovascular or toxic effects were noted. This technique of vecuronium infusion to facilitate mechanical ventilation of the lungs is feasible and satisfactory in clinical use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673644     DOI: 10.1007/BF03008139

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  19 in total

1.  The response of the newborn infant to muscle relaxants.

Authors:  A L STEAD
Journal:  Br J Anaesth       Date:  1955-03       Impact factor: 9.166

2.  Pancuronium and the neonate.

Authors:  E J Bennett; S Ramamurthy; F Y Dalal; M R Salem
Journal:  Br J Anaesth       Date:  1975-01       Impact factor: 9.166

3.  Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients.

Authors:  V Segredo; M A Matthay; M L Sharma; L D Gruenke; J E Caldwell; R D Miller
Journal:  Anesthesiology       Date:  1990-03       Impact factor: 7.892

4.  Failure of metronidazole to alter a vecuronium neuromuscular blockade in humans.

Authors:  A d'Hollander; S Agoston; V Capouet; L Barvais; J P Bomblet; M Esselen
Journal:  Anesthesiology       Date:  1985-07       Impact factor: 7.892

Review 5.  Antibiotics and neuromuscular function.

Authors:  M D Sokoll; S D Gergis
Journal:  Anesthesiology       Date:  1981-08       Impact factor: 7.892

6.  Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants?

Authors:  O A Meretoja
Journal:  Br J Anaesth       Date:  1989-02       Impact factor: 9.166

7.  Vecuronium infusion requirements in pediatric patients during fentanyl-N2O-O2 anesthesia.

Authors:  O A Meretoja
Journal:  Anesth Analg       Date:  1989-01       Impact factor: 5.108

8.  Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.

Authors:  D M Fisher; C O'Keeffe; D R Stanski; R Cronnelly; R D Miller; G A Gregory
Journal:  Anesthesiology       Date:  1982-09       Impact factor: 7.892

9.  Vecuronium infusions in patients with renal failure in an ITU.

Authors:  C L Smith; J M Hunter; R S Jones
Journal:  Anaesthesia       Date:  1987-04       Impact factor: 6.955

10.  Vecuronium kinetics and dynamics in anesthetized infants and children.

Authors:  D M Fisher; K Castagnoli; R D Miller
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.